|
Thursday, April 24, 2025
1:00 pm - 2:00 pm ET
(Noon - 1:00 pm CT/11:00 am - Noon MT/10:00 am - 11:00 am PT)
Webinar: Considerations for Conducting a 340B Drug Pricing Program Internal Audit
Speaker
Melaney Scott, MBA, CIA, CHC, Director, Health Care Compliance and Internal Audit, Moss Adams LLP
Melaney has provided internal audit and compliance services since 2007. She serves a variety of health care clients, including health systems, provider groups, long term care, and behavior health providers. She works with governments, not-for-profits, Federally Qualified Health Centers, Community Health Centers, and Tribal entities.
Melaney’s experience includes managing the planning, preparation, and execution of a variety of engagements including risk-based internal audits; HIPAA Privacy and Breach Notification Rule assessments; compliance program gap assessments; compliance program development assistance; 340B Drug Pricing Program internal audits and program development; and operational and financial related internal audits.
Her experience includes physician agreements policies and procedure review and development, data analytics, vendor management, business operations, and joint venture agreements. She also has extensive experience with audits and services based on COSO, GASB, GAAS, GAGAS, and IIA standards. Melaney has also completed the 340B University.
Webinar Description:
As a covered entity participating in or just getting started with the 340B Drug Pricing Program, there are a myriad of requirements to maintain eligibility. Participation in the 340B Drug Pricing Program allows organizations to serve more patients through the savings obtained and would be detrimental for an organization to lose. Developing an effective program is of tantamount importance and requires cross-functional collaboration and involvement throughout the organization. Internal audit can provide value to an organization by performing a 340B Drug Pricing Program Internal Audit that considers key aspects of the 340B Drug Pricing Program.
In this session we will discuss what the Health Resources and Services Administration (HRSA) generally looks at during an audit. We'll cover the key program areas surrounding a 340B Drug Pricing Program and typical causes of non-compliance in an entity's 340B Drug Pricing Program. We will discuss strategies internal audit can use to conduct a 340B Drug Pricing Program internal audit.
Learning Objectives:
- Discuss the key areas of the 340B Drug Pricing Program
- Describe common areas of non-compliance and how internal audit can leverage when planning an internal audit.
- Explain the key elements to include in a 340B Drug Pricing Program internal audit.
Cost:
Members - COMPLIMENTARY (You MUST be a current member to take advantage of this benefit.)
Program Level: All
Field of Study: Specialized Knowledge
Prerequisites: None
Delivery Method: Group Internet Based
CPE Credits: 1.0 CPE credit
Please Note: If you wish to receive continuing professional education credits for participating in the discussion, you are required to register and pay the registration fees (if applicable). You will also be required to answer 3 of the 4 questions asked online during the discussion to qualify for CPE credit.
|
